Accord Ferrous Sulphate 200mg 100 Tablets are iron supplement tablets designed to support healthy iron levels in individuals diagnosed with or at risk of iron-deficiency anaemia. They include dried ferrous sulphate, providing about 65 mg of elemental iron per tablet, a commonly used strength in clinical practice. These tablets are suitable for adults and older children advised by a healthcare professional to undergo iron therapy, offering a reliable option for continuous iron support.

Key Features

• Clinically proven iron support: Contains 200 mg ferrous sulphate, equivalent to 65 mg elemental iron, for iron-deficiency anaemia.
• Pharmacy-grade formulation: Film or sugar-coated tablets from Accord-UK Ltd for consistent quality and reliable dosing.
• Convenient larger pack size: 100-tablet pack suited for longer-term treatment and prevention regimes when prescribed.

Is Accord Ferrous Sulphate 200mg 100 Tablets suitable for treating iron-deficiency anaemia?

Accord Ferrous Sulphate 200mg tablets are specifically licensed for the prevention and treatment of iron-deficiency anaemia. Each tablet provides 200 mg dried ferrous sulphate, equivalent to 65 mg ferrous iron, a standard therapeutic dose recommended in clinical guidelines.

How does Accord Ferrous Sulphate 200mg 100 Tablets compare with other iron supplements?

These tablets use ferrous sulphate, one of the most widely studied forms of oral iron. The 200 mg strength is intended for confirmed deficiency, offering a more targeted medicinal approach compared to lower-dose multivitamin products.

Who should consider Accord Ferrous Sulphate 200mg 100 Tablets?

Accord Ferrous Sulphate 200mg tablets are suitable for adults, the elderly, and certain older children who have been assessed for iron deficiency and advised by a healthcare professional. Individuals with iron-deficiency anaemia due to dietary shortfalls or blood loss may be recommended these tablets as part of their treatment plan.

Patient Information Leaflet

• Each film-coated tablet contains dried ferrous sulfate 200 mg, equivalent to 65 mg ferrous iron (Fe II).
• Other ingredients include microcrystalline cellulose (E460(i)), pregelatinised starch, crospovidone, colloidal anhydrous silica, magnesium stearate (E572), polyvinyl alcohol (E1203), talc (E553B), titanium dioxide (E171), glycerol monocaprylocaprate (E471), sodium lauryl sulfate (E487), macrogol (PEG) polyvinyl alcohol graft-copolymer (E1209) and aspartame (E951).

Adults and elderly - prevention of iron-deficiency anaemia: one tablet daily.

Treatment of iron-deficiency anaemia: one tablet two to three times daily.

Swallow whole with water. Do not suck, chew or keep the tablet in the mouth. Do not take with tea, milk or eggs. Treatment should not continue for more than three months after the anaemia is controlled,

• Do not take if you are allergic to ferrous sulfate or any of the other ingredients.
• Do not take if you have an iron-storage disorder, active stomach ulcer, inflammatory bowel condition, haemolytic anaemia, repeated blood transfusions, or if you are already taking another iron-containing medicine.
• Speak to a doctor or pharmacist before taking if you have:
  • Had part or all of your stomach removed.
  • A history of stomach ulcers.
  • Diabetes.
  • Inflammatory bowel disease.
  • Diverticular disease.
  • Iron overload.
  • Narrowing of the intestines.
  • Vitamin B12 or folic acid deficiency.
  • Difficulty swallowing.
• If a tablet enters the airway after choking, seek medical advice urgently.
• Some medicines and mineral supplements may interact with ferrous sulfate.
• During the first 12 weeks of pregnancy, take only if specifically recommended by a doctor.
• KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.

• Seek immediate medical help if you develop an allergic reaction such as:
  • Rash.
  • Itching.
  • Difficulty breathing.
• Other possible side-effects include:
  • Stomach upset or stomach pain.
  • Nausea.
  • Vomiting.
  • Diarrhoea.
  • Constipation.
  • Dark stools.
  • Loss of appetite.
• Irritation or ulceration of the gullet may occur if the tablet becomes stuck.
• Incorrect use may cause mouth ulceration.
• People with swallowing difficulties may be at increased risk of throat, oesophageal or bronchial ulceration.
• Side-effects can be reported through the MHRA Yellow Card Scheme.